(Q43720996)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11524148%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Reduction of cortical amyloid beta levels in guinea pig brain after systemic administration of physostigmine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11524148%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11524148%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

T G Beach

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11524148%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

C Schwab

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11524148%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

D G Walker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11524148%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A E Roher

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11524148%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11524148%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11524148%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11524148%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11524148%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

21-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11524148%20AND%20SRC:MED&resulttype=core&format=json

Reduction of cerebrospinal fluid amyloid beta after systemic administration of M1 muscarinic agonists

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

Amyloid precursor protein in guinea pigs--complete cDNA sequence and alternative splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

Donepezil: a review of its use in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

The muscarinic M1 agonist xanomeline increases soluble amyloid precursor protein release from chinese hamster ovary-m1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

Regulated secretion of beta-amyloid precursor protein in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

Relation of brain regional physostigmine concentration to cholinesterase activity and acetylcholine and choline levels in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

Pharmacological modulation of Alzheimer's beta-amyloid precursor protein levels in the CSF of rats with forebrain cholinergic system lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

Genetics of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

Cholinesterase inhibitors increase secretion of APPs in rat brain cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

Muscarinic M1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

Cellular mechanisms of beta-amyloid production and secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid beta-protein production in human neuronal NT2N cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902076-6

7 January 2021

10.1016/S0304-3940(01)02076-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11524148%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference